MedTrace Logo

Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes

NCT02023242 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 152

Last updated 2019-12-10

Study results available
· View outcomes & findings →

Summary

This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.

Conditions

  • Primary Open Angle Glaucoma
  • Pseudoexfoliative Glaucoma
  • Pigmentary Glaucoma

Interventions

DEVICE

Hydrus Microstent

Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.

DEVICE

iStent Trabecular Micro Bypass

Device inserted into Schlemm's canal to enhance aqueous flow from the anterior chamber.

Sponsors & Collaborators

  • Ivantis, Inc.

    lead INDUSTRY

Principal Investigators

  • Julian Garcia Feijoo, Prof. Med. · Madrid, Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2017-08-31
Completion
2018-01-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02023242 on ClinicalTrials.gov